Ningxia Zhongke Biotechnology Co., Ltd (SHA:600165)
China · Delayed Price · Currency is CNY 3.050
-0.150 (-4.69%)
May 21, 2026, 3:00 PM CST
SHA:600165 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -90.62 | -90.38 | -538.91 | -464.71 | -141.48 | -166.09 |
Depreciation & Amortization | 127.78 | 127.78 | 127.44 | 137.85 | 122.84 | 59.85 |
Other Amortization | 1.27 | 1.27 | 1.16 | 1.12 | 0.85 | 0.87 |
Loss (Gain) From Sale of Assets | -3.66 | -3.66 | 0.95 | -0.21 | 0.06 | -2.1 |
Asset Writedown & Restructuring Costs | 111.37 | 111.37 | 107.99 | 185.07 | 23.66 | - |
Loss (Gain) From Sale of Investments | -340.99 | -340.99 | 83.26 | -34.18 | -34.96 | -39.77 |
Provision & Write-off of Bad Debts | 2.99 | 2.99 | 0.21 | -1.16 | 0.12 | -0.27 |
Other Operating Activities | -12.1 | 66.66 | 184.1 | 127.08 | 91.07 | 64.25 |
Change in Accounts Receivable | -45.68 | -45.68 | -18.01 | -25.44 | -16.69 | 4.58 |
Change in Inventory | -50.31 | -50.31 | -1.7 | 35.33 | 60.58 | -121.37 |
Change in Accounts Payable | -153.71 | -153.71 | -24.15 | 60.37 | -54.5 | 181.53 |
Change in Other Net Operating Assets | -0.64 | -0.64 | -5.5 | 2.32 | -1.12 | - |
Operating Cash Flow | -452.4 | -373.4 | -85.19 | 23.15 | 53.14 | -17.93 |
Operating Cash Flow Growth | - | - | - | -56.43% | - | - |
Capital Expenditures | -291.27 | -271.17 | -6.2 | -57.68 | -59.31 | -240.39 |
Sale of Property, Plant & Equipment | 1.14 | 1.14 | 1.44 | 4.21 | - | 2.6 |
Cash Acquisitions | - | - | - | -2.21 | -498 | -32 |
Divestitures | - | - | - | - | - | 250.07 |
Investment in Securities | - | - | - | - | 14.11 | 14.11 |
Investing Cash Flow | -290.13 | -270.03 | -4.76 | -55.68 | -543.2 | -5.61 |
Long-Term Debt Issued | - | 327 | 64.25 | 275.36 | 1,426 | 729.6 |
Total Debt Issued | 327 | 327 | 64.25 | 275.36 | 1,426 | 729.6 |
Long-Term Debt Repaid | - | -420.45 | -61.76 | -248.4 | -929.07 | -746.06 |
Total Debt Repaid | -408.49 | -420.45 | -61.76 | -248.4 | -929.07 | -746.06 |
Net Debt Issued (Repaid) | -81.49 | -93.45 | 2.49 | 26.96 | 496.53 | -16.46 |
Issuance of Common Stock | 1,241 | 1,241 | - | - | - | - |
Common Dividends Paid | -5.22 | -1.69 | -3.65 | -23.25 | -53.14 | -55.29 |
Other Financing Activities | -153.52 | -52.04 | 76.72 | 7.99 | - | - |
Financing Cash Flow | 1,001 | 1,094 | 75.56 | 11.7 | 443.39 | -71.75 |
Foreign Exchange Rate Adjustments | 0.17 | 0.2 | 0.75 | 0.55 | 2.53 | -0.69 |
Net Cash Flow | 258.73 | 450.91 | -13.64 | -20.28 | -44.13 | -95.98 |
Free Cash Flow | -743.67 | -644.57 | -91.39 | -34.53 | -6.17 | -258.32 |
Free Cash Flow Margin | -158.80% | -145.02% | -26.47% | -12.09% | -0.91% | -103.86% |
Free Cash Flow Per Share | -0.40 | -0.40 | -0.13 | -0.05 | -0.01 | -0.38 |
Cash Income Tax Paid | 32.82 | 27.21 | 12.55 | 9.8 | -21.66 | 19.73 |
Levered Free Cash Flow | -1,661 | -1,432 | 168.46 | 42.43 | 64.39 | 2.8 |
Unlevered Free Cash Flow | -1,644 | -1,415 | 259.31 | 131.51 | 121.81 | 22.35 |
Change in Working Capital | -248.44 | -248.44 | -51.4 | 72.3 | -9.01 | 65.33 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.